Funder
National Breast Cancer Foundation
National Health and Medical Research Council
Cancer Council South Australia
Reference36 articles.
1. Clinical potential of novel therapeutic targets in breast cancer: CDK4/6, Src, JAK/STAT, PARP, HDAC, and PI3K/AKT/mTOR pathways;Hosford;Pharmgenomics Pers Med,2014
2. Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials (Review);Zhang;Biomed Rep,2014
3. Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2- advanced breast cancer;Corona;Drug Des Dev Ther,2018
4. ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5);Cardoso;Ann Oncol : Off J Eur Soc Med Oncol,2020
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献